BIOMERIEUX (P.S.) O.N./ FR0013280286 /
| 2024-11-08 2:33:15 PM | Chg. -0.40 | Volume | Bid9:59:59 PM | Ask9:59:59 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 101.30EUR | -0.39% | 29 Turnover: 2,935.60 |
102.30Bid Size: 11 | 102.80Ask Size: 11 | 12.11 bill.EUR | 0.83% | 33.76 |
Assets
| 2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 404.8000 | 486.9000 | 573.6000 | 734.5000 | 711.4000 | ||||||
| Intangible Assets | 149.7000 | 460.1000 | 476.5000 | 492.6000 | 430.7000 | ||||||
| Long-Term Investments | 31.9000 | 35.1000 | 60 | 36.9000 | 57.9000 | ||||||
| Fixed Assets | 950.1000 | 1,528.3000 | 1,671.6000 | 1,845.8000 | 1,708.5000 | ||||||
| Inventories | 261.7000 | 299.2000 | 355.8000 | 404.4000 | 380.3000 | ||||||
| Accounts Receivable | 420.5000 | 449.3000 | 445.1000 | 465.8000 | 460.1000 | ||||||
| Cash and Cash Equivalents | 428 | 119.7000 | 147.1000 | 178.6000 | 312.1000 | ||||||
| Current Assets | 1,196.2000 | 991.4000 | 1,096.1000 | 1,183 | 1,279.4000 | ||||||
| Total Assets | 2,196.6000 | 2,580.5000 | 2,773.6000 | 3,028.8000 | 2,990 | ||||||
Liabilities
| 2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 132.3000 | 188.9000 | 176.9000 | 175.6000 | 161.3000 | ||||||
| Long-term debt | 304.6000 | 305.7000 | 308.9000 | 365.4000 | 391.1000 | ||||||
| Liabilities to Banks | 403.1000 | 369.2000 | 370.7000 | 453.3000 | 468 | ||||||
| Provisions | 119.1000 | 261.6000 | 291.3000 | 319.1000 | 244.6000 | ||||||
| Liabilities | 929.3000 | 1,191.9000 | 1,271 | 1,407.4000 | 1,253.3000 | ||||||
| Share Capital | 12 | 12 | 12 | 12 | 12 | ||||||
| Total Equity | 1,260.8000 | 1,380.9000 | 1,494.5000 | 1,619.1000 | 1,737.6000 | ||||||
| Minority Interests | 6.5000 | 7.8000 | 8.1000 | 2.2000 | -.9000 | ||||||
| Total liabilities equity | 2,196.6000 | 2,580.5000 | 2,773.6000 | 3,028.8000 | 2,990 | ||||||
Income Statement
| 2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,587.9000 | 1,698.4000 | 1,964.6000 | 2,103.2000 | 2,288.2000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 257.5000 | 203.6000 | 194.9000 | 282.5000 | 314.9000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | 243.5000 | 187.2000 | 176.6000 | 259.3000 | 292.1000 | ||||||
| Income Taxes | -78.8000 | -51.7000 | -66.3000 | -80.1000 | -54.5000 | ||||||
| Minority Interests Profit | -.4000 | -.6000 | .2000 | -.1000 | .6000 | ||||||
| Net Income | 164.3000 | 134.9000 | 110.5000 | 179.1000 | 238.1000 | ||||||
Per Share
Cash Flow
| 2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 240.5000 | 298.3000 | 310 | 335.6000 | 357.5000 | ||||||
| Cash Flow from Investing Activities | -128.6000 | -502.7000 | -208 | -257.2000 | -180.4000 | ||||||
| Cash Flow from Financing | 250.6000 | -83.4000 | -62.1000 | -52.5000 | -68.7000 | ||||||
| Decrease / Increase in Cash | 362.5000 | -287.8000 | 39.8000 | 25.9000 | 108.4000 | ||||||
| Employees | 7,724 | 8,695 | 9,178 | 9,664 | 10,321 | ||||||
